Zojwalla Naseem
SEC insider (Form 3/4/5 filer). CIK 0001905871. CHIEF MEDICAL OFFICER at Olema Pharmaceuticals, Inc. (OLMA). 16 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in SAN FRANCISCO, CA.
Companies Zojwalla Naseem has filed insider reports for
- Olema Pharmaceuticals, Inc. (OLMA): Officer, CHIEF MEDICAL OFFICER
Zojwalla Naseem
CIK: 0001905871
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Olema Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectPerformance Stock Options (Right to Buy)
106.3K shares- - Feb 2, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
250K shares- - Dec 23, 2025OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect50K shares at avg. $7.02$351K - Dec 23, 2025OLMA
Olema Pharmaceuticals, Inc.
SaleDirect99.5K shares at avg. $27.66$2.8M - Dec 22, 2025OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect42.8K shares at avg. $15.25$653K - Dec 22, 2025OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect7.2K shares at avg. $7.02$50K - Dec 22, 2025OLMA
Olema Pharmaceuticals, Inc.
SaleDirect100K shares at avg. $28.04$2.8M - Dec 19, 2025OLMA
Olema Pharmaceuticals, Inc.
SaleDirect12.9K shares at avg. $28.93$374K - Dec 19, 2025OLMA
Olema Pharmaceuticals, Inc.
ExerciseDirect40K shares at avg. $15.25$610K - Dec 19, 2025OLMA
Olema Pharmaceuticals, Inc.
SaleDirect57.1K shares at avg. $28.03$1.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Performance Stock Options (Right to Buy) | 106,250 | - | - | Direct |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Dec 23, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 50,000 | $7.02 | $351,000 | Direct |
| Dec 23, 2025 | OLMA Olema Pharmaceuticals, Inc. | Sale | 99,509 | $27.66 | $2,752,419 | Direct |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 42,818 | $15.25 | $652,975 | Direct |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 7,182 | $7.02 | $50,418 | Direct |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc. | Sale | 100,000 | $28.04 | $2,804,000 | Direct |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Sale | 12,921 | $28.93 | $373,805 | Direct |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise | 40,000 | $15.25 | $610,000 | Direct |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc. | Sale | 57,079 | $28.03 | $1,599,924 | Direct |
1-10 of 16 transactions